Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1970 Aug;45(242):485–490. doi: 10.1136/adc.45.242.485

A Disorder of Tryptophan Metabolism in Chronic Granulomatous Disease

A F Heeley, Mary E Heeley, Jennifer Hardy, J F Soothill
PMCID: PMC1647666  PMID: 4248383

Abstract

5 children with chronic granulomatous disease had a disorder of tryptophan metabolism, resulting in excretion of gross excess of hydroxykynurenine, kynurenine, and xanthurenic acid, with or without tryptophan loading. Hydroxykynurenine predominated, and in this and other ways the findings were different from those present in most defects of tryptophan metabolism, but were similar to those in pyridoxine deficiency. Oral pyridoxine 30 mg./day corrected this defect, but had no effect on the nitroblue tetrazolium reaction, or bacterial killing by polymorphonuclear leucocytes.

Full text

PDF
490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman K., Greengard O. Correlation of kynurenine excretion with liver tryptophan pyrrolase levels in disease and after hydrocortisone induction. J Clin Invest. 1966 Oct;45(10):1527–1534. doi: 10.1172/JCI105459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BERENDES H., BRIDGES R. A., GOOD R. A. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957 May;40(5):309–312. [PubMed] [Google Scholar]
  3. Baehner R. L., Karnovsky M. L. Deficiency of reduced nicotinamide-adenine dinucleotide oxidase in chronic granulomatous disease. Science. 1968 Dec 13;162(3859):1277–1279. doi: 10.1126/science.162.3859.1277. [DOI] [PubMed] [Google Scholar]
  4. Baehner R. L., Nathan D. G. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968 May 2;278(18):971–976. doi: 10.1056/NEJM196805022781801. [DOI] [PubMed] [Google Scholar]
  5. Denckla W. D., Dewey H. K. The determination of tryptophan in plasma, liver, and urine. J Lab Clin Med. 1967 Jan;69(1):160–169. [PubMed] [Google Scholar]
  6. Heeley A. F., Piesowicz A. T., McCubbing D. G. The biochemical and clinical effect of pyridoxine in children with brain disorders. Clin Sci. 1968 Oct;35(2):381–389. [PubMed] [Google Scholar]
  7. Heeley A. F. The effect of pyridoxine on tryptophan metabolism in phenylketonuria. Clin Sci. 1965 Dec;29(3):465–473. [PubMed] [Google Scholar]
  8. KOMROWER G. M., WILSON V., CLAMP J. R., WESTALL R. G. HYDROXYKYNURENINURIA: A CASE OF ABNORMAL TRYPTOPHAN METABOLISM PROBABLY DUE TO A DEFICIENCY OF KYNURENINASE. Arch Dis Child. 1964 Jun;39:250–256. doi: 10.1136/adc.39.205.250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. MICHAEL A. F., DRUMMOND K. N., DOEDEN D., ANDERSON J. A., GOOD R. A. TRYPTOPHAN METABOLISM IN MAN. J Clin Invest. 1964 Sep;43:1730–1746. doi: 10.1172/JCI105048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. MUSAJO L., BENASSI C. A. ASPECTS OF DISORDERS OF THE KYNURENINE PATHWAY OF TRYPTOPHAN METABOLISM IN MAN. Adv Clin Chem. 1964;7:63–135. doi: 10.1016/s0065-2423(08)60373-x. [DOI] [PubMed] [Google Scholar]
  11. Miller L. T., Linkswiler H. Effect of protein intake on the development of abnormal tryptophan metabolism by men during vitamin B6 depletion. J Nutr. 1967 Sep;93(1):53–59. doi: 10.1093/jn/93.1.53. [DOI] [PubMed] [Google Scholar]
  12. PRICE J. M., BROWN R. R., LARSON F. C. Quantitative studies on human urinary metabolites of tryptophan as affected by isoniazid and deoxypyridoxine. J Clin Invest. 1957 Nov;36(11):1600–1607. doi: 10.1172/JCI103559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. QUAGLIARIELLO E., TANCREDI F., SACCONE C., PIAZZA M. Interrelation between tryptophan and nicotinic acid in human viral hepatitis. Nature. 1962 Jun 9;194:976–977. doi: 10.1038/194976b0. [DOI] [PubMed] [Google Scholar]
  14. Quie P. G., White J. G., Holmes B., Good R. A. In vitro bactericidal capacity of human polymorphonuclear leukocytes: diminished activity in chronic granulomatous disease of childhood. J Clin Invest. 1967 Apr;46(4):668–679. doi: 10.1172/JCI105568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thompson E. N., Soothill J. F. Chronic granulomatous disease: quantitative clinicopathological relationships. Arch Dis Child. 1970 Feb;45(239):24–32. doi: 10.1136/adc.45.239.24. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. WEISSBACH H., KING W., SJOERDSMA A., UDENFRIEND S. Formation of indole-3-acetic acid and tryptamine in animals: a method for estimation of indole-3-acetic acid in tissues. J Biol Chem. 1959 Jan;234(1):81–86. [PubMed] [Google Scholar]
  17. Windhorst D. B., Holmes B., Good R. A. A newly defined X-linked trait in man with demonstration of the Lyon effect in carrier females. Lancet. 1967 Apr 8;1(7493):737–739. doi: 10.1016/s0140-6736(67)91360-8. [DOI] [PubMed] [Google Scholar]
  18. Yarbro M. T., Anderson J. A. L-tryptophan metabolism in phenylketonuria. J Pediatr. 1966 Jun;68(6):895–904. doi: 10.1016/s0022-3476(66)80208-1. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES